Junshengtai Pharmaceutical-B (02511) plummeted by 41% to a low of HK$0.72, continuing to hit a new listing low. The current market value is less than HK$0.5 billion, and over HK$6 billion has evaporated from the highest value.
The Zhitong Finance App learned that Junshengtai Pharmaceutical-B (02511) plummeted by 41% to a low of HK$0.72 and continued to hit a new listing low. The current market value is less than HK$0.5 billion, and over HK$6 billion has evaporated from the highest value. As of press release, it decreased by 38.89% to HK$0.77, with a turnover of HK$4.4873 million.
According to the news, the Shanghai Stock Exchange and Shenzhen Stock Exchange issued announcements to make adjustments to the Hong Kong Stock Exchange's securities list. Among them, Junshengtai Pharmaceutical was transferred out of Hong Kong Stock Connect, effective September 10. Junshengtai Pharmaceutical achieved additional revenue and revenue of 38.273 million yuan (RMB, same below) in the first half of this year, an increase of 68.44% over the previous year; parent company owners should have accounted for a loss of 0.211 billion yuan, a year-on-year decrease of 61.63%. As of June 30, 2024, the company's cash and bank balance was $0.3924 billion, a year-on-year decrease of 35.5%.
